InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Stewart Murray. Director active across 1 company, notably X4 Pharmaceuticals, Inc. Aggregated, 4 reports have been recorded. History available since 6 June 2022. The latest transaction was disclosed on 9 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Stewart Murray has 4 filings in total, all concerning X4 Pharmaceuticals, Inc, where he is a Director. The sampled filings cover the period from 2022-06-27 to 2025-06-10, with buy and sell amounts of EUR 0, and the transaction nature shown is Attribution.